Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Jan 26, 2023

SELL
$2.87 - $7.01 $197,625 - $482,701
-68,859 Reduced 63.01%
40,417 $130,000
Q2 2022

Aug 15, 2022

BUY
$3.76 - $6.29 $136,236 - $227,905
36,233 Added 49.61%
109,276 $613,000
Q1 2022

May 11, 2022

BUY
$5.03 - $9.61 $166,206 - $317,543
33,043 Added 82.61%
73,043 $451,000
Q4 2021

Feb 15, 2022

BUY
$8.12 - $10.37 $167,174 - $213,497
20,588 Added 106.06%
40,000 $357,000
Q3 2021

Nov 12, 2021

BUY
$7.48 - $11.38 $145,201 - $220,908
19,412 New
19,412 $189,000

Others Institutions Holding CODX

About Co-Diagnostics, Inc.


  • Ticker CODX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 33,781,000
  • Market Cap $25M
  • Description
  • Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...
More about CODX
Track This Portfolio

Track State Of Tennessee, Treasury Department Portfolio

Follow State Of Tennessee, Treasury Department and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Tennessee, Treasury Department, based on Form 13F filings with the SEC.

News

Stay updated on State Of Tennessee, Treasury Department with notifications on news.